Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women

Journal of the Chinese Medical Association

Volumn 75, Issue 2, 2012, Pages 70-74

  Chao, Kuan Chong ^a,b   Ho, Chi Hong ^a,b   Shyong, Wen Yuann ^a   Huang, Chen Yu ^a   Tsai, Shu Chuan ^a   Cheng, Hsin Yi ^a   Chou, Luoh Chyi ^a   Lin, Chih Hsiu ^a   Li, Hsin Yang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Anti Mullerian hormone; Menopause; Ovarian reserve; Polycystic ovarian syndrome

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; SENSITIVITY AND SPECIFICITY;

ADULT; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; FEMALE; HUMANS; MIDDLE AGED; OVARY; POLYCYSTIC OVARY SYNDROME; TAIWAN;

EID: 84862826850     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.12.007     Document Type: Article

References (19)

1. La Marca A., Broekmans F.J., Volpe A., Fauser B.C., Macklon N.S. Anti-Mullerian hormone (AMH): what do we still need to know?. Hum Reprod 2009, 24:2264-2275.
2. Broekmans F.J., Visser J.A., Laven J.S., Broer S.L., Themmen A.P., Fauser B.C. Anti-Mullerian hormone and ovarian dysfunction. Trends Endocrinol Metab 2008, 19:340-347.
3. Hagen C.P., Aksglaede L., Sørensen K., Main K.M., Boas M., Cleemann L., et al. Serum levels of anti-Mullerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab 2010, 95:5003-5010.
4. La Marca A., Sighinolfi G., Radi D., Argento C., Baraldi E., Artenisio A.C., et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010, 16:113-130.
5. Van Disseldorp J., Lambalk C.B., Kwee J., Looman C.W., Eijkemans M.J., Fauser B.C., et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2010, 25:221-227.
6. Rajpert-De Meyts E., Jorgensen N., Graem N., Muller J., Cate R.L., Skakkebaek N.E. Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999, 84:3836-3844.
7. Broer S.L., Mol B., Dolleman M., Fauser B.C., Broekmans F.J. The role of anti-Mullerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010, 22:193-201.
8. Sowers M.R., Eyvazzadeh A.D., McConnell D., Yosef M., Jannausch M.L., Zhang D., et al. Anti-Mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008, 93:3478-3483.
9. Tehrani F.R., Solaymani-Dodaran M., Azizi F. A single test of anti-Mullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause 2009, 16:797-802.
10. Van Disseldorp J., Faddy M.J., Themmen A.P., de Jong F.H., Peeters P.H., Van der Schouw Y.T., et al. Relationship of serum anti-Mullerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008, 93:2129-2134.
11. Yildiz B.O., Azziz R. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society. Fertil Steril 2010, 94:690-693.
12. Piltonen T., Morin-Papunen L., Koivunen R., Perheentupa A., Ruokonen A., Tapanainen J.S. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005, 20:1820-1826.
13. Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91:941-945.
14. Matzuk M.M., Lamb D.J. The biology of infertility: research advances and clinical challenges. Nat Med 2008, 14:1197-1213.
15. Weenen C., Laven J.S., Von Bergh A.R., Cranfield M., Groome N.P., Visser J.A., et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004, 10:77-83.
16. La Marca A., De Leo V., Giulini S., Orvieto R., Malmusi S., Giannella L., et al. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause. J Soc Gynecol Investig 2005, 12:545-548.
17. Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab 2007, 92:240-245.
18. Das M., Gillott D.J., Saridogan E., Djahanbakhch O. Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 2008, 23:2122-2126.
19. Seifer D.B., Golub E.T., Lambert-Messerlian G., Benning L., Anastos K., Watts D.H., et al. Variations in serum Müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 2009, 92:1674-1678.